BioNTech's BNT324 aims to outpace rivals in cancer treatment with its unique bispecific antibody design. Read more here.

CoreWeave posted 420% revenue growth and major wins, with higher CapEx seen as necessary, not negative, despite near-term ...

Gain insights, see trends and get real-time updates when you securely link or manually add your brokerage accounts.

Our premium News+ ad-free experience – only $10 more every 4 weeks!

Toyota continues to move its electrified vehicle portfolio forward by announcing its 2026 bZ Battery Electric Vehicle (BEV).